Christoph Kleinschnitz

24.9k total citations · 1 hit paper
440 papers, 13.8k citations indexed

About

Christoph Kleinschnitz is a scholar working on Molecular Biology, Neurology and Genetics. According to data from OpenAlex, Christoph Kleinschnitz has authored 440 papers receiving a total of 13.8k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Molecular Biology, 98 papers in Neurology and 93 papers in Genetics. Recurrent topics in Christoph Kleinschnitz's work include Neuroinflammation and Neurodegeneration Mechanisms (71 papers), Acute Ischemic Stroke Management (65 papers) and Multiple Sclerosis Research Studies (64 papers). Christoph Kleinschnitz is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (71 papers), Acute Ischemic Stroke Management (65 papers) and Multiple Sclerosis Research Studies (64 papers). Christoph Kleinschnitz collaborates with scholars based in Germany, United States and United Kingdom. Christoph Kleinschnitz's co-authors include Guido Stoll, Bernhard Nieswandt, Michael K. Schuhmann, Sven G. Meuth, Peter Kraft, Felix Fluri, Heinz Wiendl, Martin Bendszus, Friederike Langhauser and Simon F. De Meyer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of Clinical Investigation.

In The Last Decade

Christoph Kleinschnitz

415 papers receiving 13.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Animal models of ischemic stroke and their application in clinical research

2015 477 citations Christoph Kleinschnitz, Michael K. Schuhmann et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christoph Kleinschnitz Germany	62	3.6k	3.4k	2.3k	2.3k	2.1k	440	13.8k
Guido Stoll Germany	69	4.7k 1.3×	3.7k 1.1×	2.1k 0.9×	2.9k 1.3×	1.9k 0.9×	258	15.9k
Sven G. Meuth Germany	59	2.6k 0.7×	4.1k 1.2×	1.0k 0.4×	2.7k 1.2×	599 0.3×	561	14.0k
David J. Pinsky United States	64	2.0k 0.6×	4.1k 1.2×	1.8k 0.8×	2.8k 1.2×	916 0.4×	188	15.0k
Andreas Meisel Germany	63	4.3k 1.2×	4.1k 1.2×	3.5k 1.5×	2.0k 0.9×	579 0.3×	317	15.6k
Denis Vivien France	63	3.3k 0.9×	3.8k 1.1×	2.6k 1.1×	973 0.4×	1.1k 0.5×	323	12.4k
Gary A. Rosenberg United States	68	6.8k 1.9×	5.1k 1.5×	3.9k 1.7×	1.1k 0.5×	1.3k 0.6×	201	19.5k
Paul van der Valk Netherlands	80	4.3k 1.2×	5.8k 1.7×	1.2k 0.5×	3.3k 1.5×	495 0.2×	252	19.5k
Ralf Gold Germany	78	3.9k 1.1×	6.3k 1.8×	1.7k 0.7×	7.1k 3.1×	1.1k 0.5×	780	28.2k
Peter Vajkoczy Germany	72	2.9k 0.8×	4.7k 1.4×	2.8k 1.2×	2.0k 0.9×	327 0.2×	637	21.8k
Sylvain Doré United States	60	2.4k 0.7×	5.8k 1.7×	1.4k 0.6×	726 0.3×	903 0.4×	255	13.0k

Countries citing papers authored by Christoph Kleinschnitz

Since Specialization

Citations

This map shows the geographic impact of Christoph Kleinschnitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christoph Kleinschnitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christoph Kleinschnitz more than expected).

Fields of papers citing papers by Christoph Kleinschnitz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christoph Kleinschnitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christoph Kleinschnitz. The network helps show where Christoph Kleinschnitz may publish in the future.

Co-authorship network of co-authors of Christoph Kleinschnitz

This figure shows the co-authorship network connecting the top 25 collaborators of Christoph Kleinschnitz. A scholar is included among the top collaborators of Christoph Kleinschnitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christoph Kleinschnitz. Christoph Kleinschnitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Konen, Franz Felix, Nora Möhn, Torsten Witte, et al.. (2025). Disease-modifying strategies: Targeting protein kinases in multiple sclerosis and other autoimmune disorders. Autoimmunity Reviews. 24(4). 103754–103754.

Kleinschnitz, Christoph, Jelena Škuljec, Markus C. Kowarik, et al.. (2025). First insights into the safety and effectiveness of additional courses with cladribine tablets under real-world conditions. Multiple Sclerosis and Related Disorders. 97. 106398–106398. 1 indexed citations

Kowarik, Markus C., Michael Ernst, Lukas Cepek, et al.. (2024). Real-world therapy management of patients with multiple sclerosis receiving cladribine tablets beyond year 4 – Results from a German cladribine cohort. Multiple Sclerosis and Related Disorders. 88. 105704–105704. 5 indexed citations

Mausberg, Anne K., et al.. (2024). Targeting the neonatal Fc receptor (FcRn) is not beneficial in an animal model of chronic neuritis. Immunologic Research. 73(1). 12–12. 1 indexed citations

Dinse, Hannah, Eva‐Maria Skoda, Mark Stettner, et al.. (2024). Needs and Demands for e-Health Symptom Management Interventions in Patients with Post-COVID-19 Condition: A User-Centered Design Approach. Telemedicine Journal and e-Health. 30(8). 2194–2202. 1 indexed citations

David, Christina, Tobias Ruck, Leoni Rolfes, et al.. (2023). Impact of NKG2D Signaling on Natural Killer and T‐Cell Function in Cerebral Ischemia. Journal of the American Heart Association. 12(12). e029529–e029529. 5 indexed citations

Walker, Britta, Patrick Münzer, Bing Peng, et al.. (2023). Niemann-Pick C1 protein regulates platelet membrane–associated calcium ion signaling in thrombo-occlusive diseases in mice. Journal of Thrombosis and Haemostasis. 21(7). 1957–1966. 1 indexed citations

Frahm, Niklas, David Ellenberger, Peter Flachenecker, et al.. (2022). Therapy Switches in Fingolimod-Treated Patients with Multiple Sclerosis: Long-Term Experience from the German MS Registry. Neurology and Therapy. 11(1). 319–336. 3 indexed citations

Chen, Bixia, Dino Saban, Annika Herten, et al.. (2021). Modifiable Cardiovascular Risk Factors in Patients With Sporadic Cerebral Cavernous Malformations. Stroke. 52(4). 1259–1264. 18 indexed citations

10.

Blaschke, Stefan, David Ellenberger, Peter Flachenecker, et al.. (2021). Time to diagnosis in multiple sclerosis: Epidemiological data from the German Multiple Sclerosis Registry. Multiple Sclerosis Journal. 28(6). 865–871. 9 indexed citations

11.

Herten, Annika, Thiemo Florin Dinger, Mehdi Chihi, et al.. (2021). Subarachnoid Hemorrhage Early Brain Edema Score (SEBES) as a radiographic marker of clinically relevant intracranial hypertension and unfavorable outcome after subarachnoid hemorrhage. European Journal of Neurology. 28(12). 4051–4059. 22 indexed citations

12.

Gronewold, Janine, Miriam Engels, Sarah Van de Velde, et al.. (2021). Effects of Life Events and Social Isolation on Stroke and Coronary Heart Disease. Stroke. 52(2). 735–747. 31 indexed citations

13.

Mausberg, Anne K., Gerd Meyer zu Hörste, Michael Fleischer, et al.. (2020). NK cell markers predict the efficacy of IV immunoglobulins in CIDP. Neurology Neuroimmunology & Neuroinflammation. 7(6). 12 indexed citations

14.

Stolte, Benjamin, Saskia Bolz, Kathrin Kizina, et al.. (2020). Minimal clinically important differences in functional motor scores in adults with spinal muscular atrophy. European Journal of Neurology. 27(12). 2586–2594. 32 indexed citations

15.

Möhn, Nora, Franz Felix Konen, Refik Pul, et al.. (2020). Experience in Multiple Sclerosis Patients with COVID-19 and Disease-Modifying Therapies: A Review of 873 Published Cases. Journal of Clinical Medicine. 9(12). 4067–4067. 46 indexed citations

16.

Casas, Ana I., Pamela W. M. Kleikers, Eva Geuß, et al.. (2019). Calcium-dependent blood-brain barrier breakdown by NOX5 limits postreperfusion benefit in stroke. Journal of Clinical Investigation. 129(4). 1772–1778. 65 indexed citations

17.

Denorme, Frederik, Friederike Langhauser, Linda Desender, et al.. (2016). ADAMTS13-mediated thrombolysis of t-PA–resistant occlusions in ischemic stroke in mice. Blood. 127(19). 2337–2345. 130 indexed citations

18.

Morowski, Martina, Timo Vögtle, Peter Kraft, et al.. (2013). Only severe thrombocytopenia results in bleeding and defective thrombus formation in mice. Blood. 121(24). 4938–4947. 99 indexed citations

19.

Göbel, Kerstin, Susann Pankratz, Tilman Schneider‐Hohendorf, et al.. (2011). Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking. Journal of Autoimmunity. 36(2). 106–114. 68 indexed citations

20.

Bittner, Stefan, Nicole Bobak, Martin Feuchtenberger, et al.. (2011). Expression of K2P5.1 potassium channels on CD4+T lymphocytes correlates with disease activity in rheumatoid arthritis patients. Arthritis Research & Therapy. 13(1). R21–R21. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact